Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of premarket application (PMA) approvals. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMA's through the Internet and the agency's Dockets Management Branch.
Summaries of safety and effectiveness are available on the Internet at http://www.fda.gov/cdrh/pmapage.html. Copies of summaries of safety and effectiveness are also available by submitting a written request to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 in the Supplementary Information section of this document when submitting a written request.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Kathy M. Poneleit, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186.End Further Info End Preamble Start Supplemental Information
In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule to revise §§ 814.44(d) and 814.45(d) (21 CFR 814.44(d) and 814.45(d)) to discontinue publication of individual PMA approvals and denials in the Federal Register. Instead, revised §§ 814.44(d) and 814.45(d) state that FDA will notify the public of PMA approvals and denials by posting them on FDA's home page on the Internet at http://www.fda.gov, by placing the summaries of safety and effectiveness on the Internet and in FDA's Dockets Management Branch, and by publishing in the Federal Register after each quarter a list of available safety and effectiveness summaries of approved PMA's and denials announced in that quarter.
FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.
In accordance with section 515(d)(3) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(3)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.
The following is a list of approved PMA's for which summaries of safety and effectiveness were placed on the Internet in accordance with the procedure explained previously from October 1, 1999, through December 31, 1999. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date. Start Printed Page 16922
|PMA Number/Docket No.||Applicant||Trade Name||Approval Date|
|P970010/99M-4361||Synthes (USA)||Norian Skeletal Repair System (SRS) Cancellous Bone Cement||December 23, 1998|
|P970015/99M-4277||Sofamor Danek||Inter Fix Threaded Fusion Device||May 14, 1999|
|P960033/99M-4693||Staar Surgical||StaarviscTM Sodium Hyaluronate||July 2, 1999|
|P980053/99M-4278||Advanced Uroscience, Inc.||Durasphere Injectable Bulking Agent||September 13, 1999|
|P990008/99M-4276||Cook, Inc.||Cook MBC PTCA Balloon Dilatation Catheter||September 27, 1999|
|P990001/99M-4281||Vitatron, Inc.||Diva Platform Implantable Pulse Generators & Pro Vit Application Software Version 3.3.2||September 27, 1999|
|P990020/99M-4331||Medtronic Aneurx||Aneurx Stent Graft System||September 28, 1999|
|P980043/99M-4279||Medtronic, Inc.||Hancock II Bioprosthetic Heart Valve||September 28, 1999|
|P990017/99M-4280||Guidant Cardiac & Vascular Surgery||EVT Abdominal Aortic Tube/EVT Abdominal Aortic Bifurcated EGS System||September 28, 1999|
|P990004/99M-4776||Ethicon, Inc.||Surgifoam Absorbable Gelatin Sponge, USP||September 30, 1999|
|P940034 (S008)/99M-4782||Gen-Probe, Inc.||Gen-Probe® Amplified Mycobacterium Tuberculosis Direct Test (MTD Test)||September 30, 1999|
|P990002/99M-4330||Rochester Medical Corp.||Femsoft Urethral Insert||September 30, 1999|
|H980007/99M-4810||Shelhigh, Inc.||Shelhigh Pulmonic Valve Conduit Model NR-4000 with “No-React®” Treatment||September 30, 1999|
|P990033/99M-4692||Ceramed Corp.||PepGen P-15||October 25, 1999|
|P990014/99M-5135||Bausch & Lomb Surgical, Inc.||Hydroview Composite Hydrogel Foldable UV-Absorbing Posterior Chamber Intraocular Lens||November 12, 1999|
|H990007/99M-5327||CryoLife, Inc.||BioGlue® Surgical Adhesive||December 7, 1999|
|H980006/99M-5539||MDS Nordion, Inc.||TheraSphere®||December 10, 1999|
Dated: March 14, 2000.
Linda S. Kahan,
Deputy Director for Regulations Policy, Center for Devices and Radiological Health.
[FR Doc. 00-7780 Filed 3-29-00; 8:45 am]
BILLING CODE 4160-01-F